Daiichi Life Insurance Co. Ltd. Invests $4.31 Million in Synopsys, Inc. $SNPS

Daiichi Life Insurance Co. Ltd. bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) in the second quarter, Holdings Channel.com reports. The fund bought 9,655 shares of the semiconductor company’s stock, valued at approximately $4,307,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Commerce Bank purchased a new position in Synopsys in the 2nd quarter worth about $4,107,000. Northwestern Mutual Wealth Management Co. purchased a new stake in Synopsys in the 2nd quarter valued at about $6,965,000. Evolve Private Wealth LLC purchased a new stake in Synopsys in the 2nd quarter valued at about $1,024,000. WealthShield Partners LLC bought a new position in Synopsys in the 2nd quarter worth about $217,000. Finally, Farringdon Capital Ltd. bought a new position in Synopsys in the 2nd quarter worth about $445,000. 85.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. BNP Paribas Exane lifted their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Robert W. Baird set a $558.00 price objective on Synopsys in a report on Thursday, May 28th. Bank of America lifted their target price on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Benchmark reiterated a “buy” rating on shares of Synopsys in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $563.59.

Synopsys Stock Performance

NASDAQ:SNPS opened at $397.87 on Monday. The firm has a 50-day simple moving average of $419.73 and a 200-day simple moving average of $440.09. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The firm has a market cap of $76.18 billion, a P/E ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company’s quarterly revenue was up 41.9% on a year-over-year basis. During the same period last year, the firm earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Buying and Selling at Synopsys

In other news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.